What the six lenses say about NEPHROPLUS — its relative strength vs the baselines, price & RS trend, the 8-quarter financials, and live filings.
How NEPHROPLUS’s own sector index is moving — context for reading the stock’s six lenses.
Six-lens read
The actual numbers
The actual numbers
Full 8-quarter history in the financials table below.
The actual numbers
The actual numbers
Every filing in the corporate-announcements panel below.
The actual numbers
Decile — each lens’s 0–100 score is ranked against every Micro-cap stock in the universe. D10 = top 10% (strongest), D1 = bottom 10%. A decile is simply where this stock sits versus its size-peers on that lens — no weighting, no black box.
Conviction — the average of the two active conviction-lens deciles (Technical & Flow):
Fundamental, Catalyst, Valuation and Policy are shown for context but carry weight 0 in the current model, so they are not scored into conviction. Full detail on the methodology page ↗.
Glass box
Click a lens to expand its sub-components, then drill to the actual values. The eye icon on any term explains it.
Policy
Active policies relevant to this sector — flagged as a Red / Amber / Green signal, not scored into the six-lens conviction. The lenses say what the market is doing; policy is context for why.
PLI Scheme — Pharmaceuticals & API
Production-linked incentive scheme for pharmaceuticals, APIs, and medical devices
Percentage-point spread vs each baseline across six windows. Green = outperforming, red = lagging. Data as of 2026-09-08.
| Baseline | 1D | 1W | 1M | 3M | 6M | 12M |
|---|---|---|---|---|---|---|
Nifty 50 Large-cap anchor | +2.5pp | +5.3pp | +6.3pp | +4.0pp | +28.8pp | — |
Nifty 500 Broad-market baseline | +2.4pp | +5.3pp | +5.2pp | +2.5pp | +23.1pp | — |
Sector Own-sector index | — | — | +3.8pp | -0.2pp | +14.4pp | — |
From atlas_foundation.technical_daily. Sector row covers 1M–12M (1D/1W not stored).
Trend
NEPHROPLUS daily close with the three trend EMAs · atlas_foundation.ohlcv_stock.
Relative strength
NEPHROPLUS ÷ Nifty 500, rebased to 100 at window start — above 100 = outperforming since then.
TradingView composite technical analysis — multi-timeframe consensus
Last 8 quarters from the company’s filings (₹ crore) — revenue, profit, margins and the growth trend.
| Metric | Dec '24 | Mar '25 | Sep '25 | Dec '25 | Mar '26 |
|---|---|---|---|---|---|
| Revenue (₹cr) | 197 | 219 | 246 | 260 | 266 |
| ↳ change QoQ | — | +11.2% | +12.3% | +5.7% | +2.3% |
| EBITDA (₹cr) | 44 | 51 | 64 | 61 | 51 |
| EBITDA margin | 22.3% | 23.3% | 26.0% | 23.5% | 19.2% |
| PAT (₹cr) | 20 | 25 | -9 | 32 | 30 |
| ↳ change QoQ | — | +25.0% | -136.0% | +455.6% | -6.3% |
| Net margin | 10.2% | 11.4% | -3.7% | 12.3% | 11.3% |
| EPS (₹) | 96.50 | 119.30 | -5.24 | 3.21 | 3.03 |
| D/E | — | — | — | — | — |
Filings to the exchange — capital actions, earnings and governance. Most recent first.
A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗…and 5 more.
Ownership
Mutual funds holding NEPHROPLUS (6)
| Fund | Weight | AUM ₹cr | Grade |
|---|---|---|---|
| SBI Healthcare Opportunities Reg Gr | 1.20% | 5,400 | |
| DSP Healthcare Fund Reg Gr | 1.19% | 3,639 | |
| Helios Small Cap Reg Gr | 1.21% | 1,455 | |
| Baroda BNP Paribas Small Cap Reg Gr | 1.59% | 1,288 | |
| WhiteOak Capital Phrm and Hlthcr Reg Gr | 0.67% | 825 | |
| Baroda BNP P Hlth and Wellness RegGr | 1.74% | 519 |
ETFs holding NEPHROPLUS (0)
No tracked ETF holds NEPHROPLUS ≥0.5%.